View in EDS

Synthetic inducible bacteria normalize the microenvironment of refractory tumors, potentiating checkpoint inhibitor responses.

Saved in:
Bibliographic Details
Title: Synthetic inducible bacteria normalize the microenvironment of refractory tumors, potentiating checkpoint inhibitor responses.
Authors: Panagi M; University of Cyprus Nicosia Cyprus., Mpekris F; Cyprus Institute of Neurology and Genetics Nicosia Cyprus., Burger Ramos M; Queen Mary University of London United Kingdom., Voutouri C; University of Cyprus Cyprus., Michael C; University of Cyprus Nicosia Cyprus., Pearce OMT; Queen Mary University of London London United Kingdom., Correa de Sampaio P; Neobe Therapeutics Cambridge United Kingdom., Soulier A; Neobe Therapeutics United Kingdom., Stylianopoulos T; University of Cyprus Nicosia Cyprus.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2026 May 01. Date of Electronic Publication: 2026 May 01.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42068084
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Synthetic inducible bacteria normalize the microenvironment of refractory tumors, potentiating checkpoint inhibitor responses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Panagi+M%22">Panagi M</searchLink>; University of Cyprus Nicosia Cyprus.<br /><searchLink fieldCode="AU" term="%22Mpekris+F%22">Mpekris F</searchLink>; Cyprus Institute of Neurology and Genetics Nicosia Cyprus.<br /><searchLink fieldCode="AU" term="%22Burger+Ramos+M%22">Burger Ramos M</searchLink>; Queen Mary University of London United Kingdom.<br /><searchLink fieldCode="AU" term="%22Voutouri+C%22">Voutouri C</searchLink>; University of Cyprus Cyprus.<br /><searchLink fieldCode="AU" term="%22Michael+C%22">Michael C</searchLink>; University of Cyprus Nicosia Cyprus.<br /><searchLink fieldCode="AU" term="%22Pearce+OMT%22">Pearce OMT</searchLink>; Queen Mary University of London London United Kingdom.<br /><searchLink fieldCode="AU" term="%22Correa+de+Sampaio+P%22">Correa de Sampaio P</searchLink>; Neobe Therapeutics Cambridge United Kingdom.<br /><searchLink fieldCode="AU" term="%22Soulier+A%22">Soulier A</searchLink>; Neobe Therapeutics United Kingdom.<br /><searchLink fieldCode="AU" term="%22Stylianopoulos+T%22">Stylianopoulos T</searchLink>; University of Cyprus Nicosia Cyprus.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2026 May 01. <i>Date of Electronic Publication: </i>2026 May 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42068084
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-25-0203
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Synthetic inducible bacteria normalize the microenvironment of refractory tumors, potentiating checkpoint inhibitor responses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Panagi M
      – PersonEntity:
          Name:
            NameFull: Mpekris F
      – PersonEntity:
          Name:
            NameFull: Burger Ramos M
      – PersonEntity:
          Name:
            NameFull: Voutouri C
      – PersonEntity:
          Name:
            NameFull: Michael C
      – PersonEntity:
          Name:
            NameFull: Pearce OMT
      – PersonEntity:
          Name:
            NameFull: Correa de Sampaio P
      – PersonEntity:
          Name:
            NameFull: Soulier A
      – PersonEntity:
          Name:
            NameFull: Stylianopoulos T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1